Literature DB >> 8277547

Increasing the completion of the durable power of attorney for health care. A randomized, controlled trial.

S M Rubin1, W M Strull, M F Fialkow, S J Weiss, B Lo.   

Abstract

OBJECTIVE: Wider use of written advance directives may prevent many ethical dilemmas about life-sustaining interventions for patients who have lost decision-making capacity. We investigated whether a simple educational intervention increased patient completion of the durable power of attorney for health care.
DESIGN: A randomized, controlled trial.
SETTING: A health maintenance organization.
SUBJECTS: All patients aged 65 years and older and discharged from a hospital between January 1991 and May 1991 (n = 1101) were randomized to either an intervention group or a control group. INTERVENTION: An educational pamphlet on the durable power of attorney for health care and a durable power of attorney for health care form were mailed to all patients in the intervention group. The control group received conventional care only. MAIN OUTCOME MEASURE: Completion of the durable power of attorney for health care form.
RESULTS: There were no significant baseline differences between the intervention group and the control group. Following our intervention, 18.5% of the subjects in the experimental group completed a durable power of attorney for health care form, compared with 0.4% of the control group (P < .0001).
CONCLUSIONS: A simple educational intervention significantly increased the completion of the durable power of attorney for health care. Our findings should stimulate further efforts to empower patients to make informed decisions about their health care.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach

Mesh:

Year:  1994        PMID: 8277547

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  15 in total

1.  Increasing the use of advance directives in medical outpatients.

Authors:  F J Landry; K Kroenke; C Lucas; J Reeder
Journal:  J Gen Intern Med       Date:  1997-07       Impact factor: 5.128

2.  Practical methods to increase use of advance medical directives.

Authors:  J B Brown; A Beck; M Boles; P Barrett
Journal:  J Gen Intern Med       Date:  1999-01       Impact factor: 5.128

Review 3.  Advance directives for non-therapeutic dementia research: some ethical and policy considerations.

Authors:  R L Berghmans
Journal:  J Med Ethics       Date:  1998-02       Impact factor: 2.903

4.  Advance directives outside the USA: are they the best solution everywhere?

Authors:  M A Sanchez-Gonzalez
Journal:  Theor Med       Date:  1997-09

5.  A Randomized Trial of Expanding Choice Sets to Motivate Advance Directive Completion.

Authors:  Katherine R Courtright; Vanessa Madden; Nicole B Gabler; Elizabeth Cooney; Jennifer Kim; Nicole Herbst; Lauren Burgoon; Jennifer Whealdon; Laura M Dember; Scott D Halpern
Journal:  Med Decis Making       Date:  2016-08-10       Impact factor: 2.583

6.  End-of-life treatment in managed care. The potential and the peril.

Authors:  S H Miles; E P Weber; R Koepp
Journal:  West J Med       Date:  1995-09

7.  Advance planning for advance directives.

Authors:  A Alpers; B Lo
Journal:  J Gen Intern Med       Date:  1994-10       Impact factor: 5.128

8.  Cross-cultural similarities and differences in attitudes about advance care planning.

Authors:  Henry S Perkins; Cynthia M A Geppert; Adelita Gonzales; Josie D Cortez; Helen P Hazuda
Journal:  J Gen Intern Med       Date:  2002-01       Impact factor: 5.128

9.  Promoting advance directives among elderly primary care patients.

Authors:  Lawrence S Wissow; Amy Belote; Wade Kramer; Amy Compton-Phillips; Robert Kritzler; Jonathan P Weiner
Journal:  J Gen Intern Med       Date:  2004-09       Impact factor: 5.128

10.  Literacy and race as risk factors for low rates of advance directives in older adults.

Authors:  Katherine R Waite; Alex D Federman; Danielle M McCarthy; Rebecca Sudore; Laura M Curtis; David W Baker; Elizabeth A H Wilson; Romana Hasnain-Wynia; Michael S Wolf; Michael K Paasche-Orlow
Journal:  J Am Geriatr Soc       Date:  2013-02-04       Impact factor: 5.562

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.